Home » Tenders » Americas » USA » Tender 139363223

Cdc Riser Industry Day Tender in USA - 139363223

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | CENTERS FOR DISEASE CONTROL AND PREVENTION has issued a Tender notice for the procurement of a Cdc Riser Industry Day in the USA. This Tender notice was published on 11 Apr 2026 and is scheduled to close on 06 May 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 139363223, while the tender notice number is 75D301-TBD-RISER and Registering on the platform.

Procurement Summary

Country: USA

Summary: Cdc Riser Industry Day

Deadline: 06 May 2026

Posting Date: 11 Apr 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 139363223

Document Ref. No.: 75D301-TBD-RISER

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Tender Details

Industry Day Announcement
75D301-TBD-RISER
CDC Industry Day
Title: Resources for the Improvement of Surveillance and Emergency Response Program (RISER)
NAICS: 325413 - In-Vitro Diagnostic Substance Manufacturing
541511 - Custom Computer Programming Services
Point of Contact: RISER team- [email protected] (Attn: Adam Dwyer)
Short Description: This project is a critical component of CDC-s efforts to ensure the availability and distribution of quality reference pathogens and other reagents to CDC and partner researchers for surveillance and public health responses. It also serves to enhance the CDC-s ability to provide on-site technical assistance to state and local public health laboratories and commercial developers of vaccines, antiviral drugs, and diagnostic tests; in support of our common goal to minimize the impact of bacterial, viral, and respiratory diseases in humans. Further, it builds on successful platforms to expand the network of CDC laboratories that can use this mechanism to further protect the safety and health of Americans.
The primary core objectives of this contract are:
To produce or acquire high-quality stocks of reference pathogens, positive controls, detection kits, genomic sequencing components, proficiency panels, and other similar types of surveillance and research reagents in direct support of CDC-developed assays and surveillance platforms;
To ensure that these reagents, and any other materials critical to the performance of public health laboratory surveillance activities, are reliably available to CDC, its public health laboratory partners, and approved research collaborators for the characterization of circulating and novel pathogens;
To sustain the operational capacity to rapidly scale reagent acquisition, production, and distribution in support of domestic and global public health emergencies;
To establish and maintain secure infrastructure for real-time data exchange across contractors and with...
Notice ID: 75d301-tbd-riser

Department/Ind. Agency: health and human services, department of

Sub-tier: centers for disease control and prevention

Office: cdc office of acquisition services

NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Inactive Dates: may 21, 2026

Inactive Policy: 15 days after response date

Documents

Browse More

All Tenders From Americas

Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA

Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services

View Tenders By